Skip to content
Governance Register

← US public companies

Deciphera Pharmaceuticals, Inc.

SEC CIK 1654151 · NA · last insider filing 2024-06-11

Directors (from insider filings)

NameCapacity as filedFilings
Allen Patricia L Director filed 2017 - 2024
Squarer Ron Director filed 2019 - 2024
Kelley Susan L. Director filed 2019 - 2024
Hoerter Steven L. Director · President and CEO filed 2018 - 2024
Benz Edward J. JR Director filed 2017 - 2024
Walsh Dennis Leo Director filed 2017 - 2024
Martin John Richard Director filed 2017 - 2024
Bristol James Arthur Director filed 2017 - 2024
Friedman Franklin Stuart Director filed 2019 - 2024
Taylor Michael Douglas Director · See Remarks filed 2017 - 2021
Ross Michael Jay Director filed 2017 - 2019
Ratcliffe Liam Director filed 2017 - 2018

Officers (from insider filings)

NameTitle as filedFilings
Sherman Matthew L EVP & Chief Medical Officer filed 2019 - 2024
Kelly Thomas Patrick Chief Financial Officer filed 2017 - 2024
Martin Daniel C. Chief Commercial Officer filed 2018 - 2024
Dhanak Dashyant EVP & Chief Scientific Officer filed 2023 - 2024
Pitman Jama See Remarks filed 2021 - 2024
Flynn Daniel Lee Chief Scientific Officer filed 2018 - 2023
Morl Christopher John Chief Business Officer filed 2018 - 2020
Ruddy Stephen B. Chief Technical Officer filed 2018 - 2019
Rosen Oliver Chief Medical Officer filed 2018 - 2018

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.